Skip to main content

Table 1  General Information of training and testing groups.

From: Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features

 

Age

Sex (Male/Female)

PR + SD (n = 57)

PD (n = 29)

Training (n = 60)

46.27 ± 12.73

26/34

40

20

Testing (n = 26)

44.15 ± 16.16

15/11

17

9

t/F value

− 0.65

1.49

0.23

 

p value

0.517

0.23

0.91